safety of glp 1 receptor agonists GLP-1 For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH Comparative efficacy and safety of

doi: 10.1111/j.1467-789X.2004.00144.x 8 BlherM

Glucagonlike peptide1 receptor agonists in adult patients with type 2 diabetes: review of cardiovascular outcome trials

Research presented at the 2025 European Association for the Study of Diabetes meeting confirmed that semaglutide users report significantly fewer obsessive thoughts about food

Pancreatitis during treatment with liraglutide

Multi-society consensus guidelines have, in general, recommended an individualized approach toward the decision to withhold GLP-1RA therapy (46)

The custom code used is available from the corresponding author upon reasonable request